Published in J Neurosurg on January 01, 1985
Steps towards cost-benefit analysis of regional neurosurgical care. BMJ (1990) 2.74
Treatment and survival of patients with nonmalignant intracranial meningioma: results from the Surveillance, Epidemiology, and End Results Program of the National Cancer Institute. Clinical article. J Neurosurg (2011) 2.39
Molecular genetic approach to human meningioma: loss of genes on chromosome 22. Proc Natl Acad Sci U S A (1987) 1.63
Primary extracranial meningiomas: an analysis of 146 cases. Head Neck Pathol (2009) 1.47
Impaired survival and long-term neurological problems in benign meningioma. Neuro Oncol (2012) 1.37
Phase II study of imatinib mesylate for recurrent meningiomas (North American Brain Tumor Consortium study 01-08). Neuro Oncol (2009) 1.30
Spinal meningiomas: critical review of 131 surgically treated patients. Eur Spine J (2008) 1.23
[68Ga]-DOTATOC-PET/CT for meningioma IMRT treatment planning. Radiat Oncol (2009) 1.16
Detection of cranial meningiomas: comparison of ⁶⁸Ga-DOTATOC PET/CT and contrast-enhanced MRI. Eur J Nucl Med Mol Imaging (2012) 1.07
Surgical outcome of spinal canal meningiomas. J Korean Neurosurg Soc (2007) 1.07
Tumors of the meninges: proposed modifications of the World Health Organization classification. Acta Neuropathol (1990) 1.02
Interinstitutional variance of postoperative radiotherapy and follow up for meningiomas in Germany: impact of changes of the WHO classification. J Neurol Neurosurg Psychiatry (2005) 1.02
Peptide receptor radionuclide therapy with (90)Y-DOTATOC in recurrent meningioma. Eur J Nucl Med Mol Imaging (2009) 0.99
Update on meningiomas. Oncologist (2011) 0.99
Predicting the probability of meningioma recurrence in the preoperative and early postoperative period: a multivariate analysis in the midterm follow-up. Skull Base (2007) 0.99
Complications after gamma knife radiosurgery for benign meningiomas. J Neurol Neurosurg Psychiatry (2003) 0.98
High symptom improvement and local tumor control using stereotactic radiotherapy when given early after diagnosis of meningioma. A multicentre study. Strahlenther Onkol (2012) 0.96
Long term experience of gamma knife radiosurgery for benign skull base meningiomas. J Neurol Neurosurg Psychiatry (2005) 0.94
Intracerebral Meningiomas. Curr Treat Options Neurol (2004) 0.93
Meningiomas. Curr Treat Options Neurol (2001) 0.92
Posterior fossa meningioma: surgical strategy. Skull Base Surg (1994) 0.92
Results of spinal meningioma surgery in patients with severe preoperative neurological deficits. Eur Spine J (2004) 0.91
Comparative protein profiling reveals minichromosome maintenance (MCM) proteins as novel potential tumor markers for meningiomas. J Proteome Res (2010) 0.91
Definitive embolization of meningiomas. A review. Interv Neuroradiol (2005) 0.89
Spinal cord tumours: advances in genetics and their implications for treatment. Nat Rev Neurol (2013) 0.88
Meningiomas infiltrating the superior sagittal sinus: surgical considerations of 328 cases. Neurosurg Rev (2006) 0.88
Differential expression profiling analyses identifies downregulation of 1p, 6q, and 14q genes and overexpression of 6p histone cluster 1 genes as markers of recurrence in meningiomas. Neuro Oncol (2010) 0.87
Meningiomas: knowledge base, treatment outcomes, and uncertainties. A RANO review. J Neurosurg (2015) 0.86
Assessment of Epidermal Growth Factor Receptor (EGFR) expression in human meningioma. Radiat Oncol (2010) 0.86
Recurrence and outcome in skull base meningiomas: do they differ from other intracranial meningiomas? Skull Base (2008) 0.86
Comparison of ⁶⁸Ga-DOTATOC-PET/CT and PET/MRI hybrid systems in patients with cranial meningioma: Initial results. Neuro Oncol (2014) 0.85
Fractionated stereotactic conformal radiotherapy for large benign skull base meningiomas. Radiat Oncol (2011) 0.84
Five fraction image-guided radiosurgery for primary and recurrent meningiomas. Front Oncol (2013) 0.84
Early recurrences in histologically benign/grade I meningiomas are associated with large tumors and coexistence of monosomy 14 and del(1p36) in the ancestral tumor cell clone. Neuro Oncol (2007) 0.83
Molecular biology of unreresectable meningiomas: implications for new treatments and review of the literature. Skull Base (2008) 0.83
Contemporary surgical outcome for skull base meningiomas. Neurosurg Rev (2011) 0.82
Mifepristone (RU 486) treatment of meningiomas. J Neurol Neurosurg Psychiatry (1992) 0.82
Usefulness of thallium-201 SPECT in the evaluation of tumor natures in intracranial meningiomas. Neuroradiology (2011) 0.82
Presentation and patterns of late recurrence of olfactory groove meningiomas. Skull Base Surg (2000) 0.81
Meningioma and schwannoma risk in adults in relation to family history of cancer. Neuro Oncol (2004) 0.81
Radiosurgery of spinal meningiomas and schwannomas. Technol Cancer Res Treat (2012) 0.81
CT and MRI findings of calcified spinal meningiomas: correlation with pathological findings. Skeletal Radiol (2009) 0.80
Surgical management of spinal meningiomas: A retrospective case analysis based on preoperative surgical grade. Surg Neurol Int (2014) 0.80
Management of benign skull base meningiomas: a review. Skull Base (2004) 0.80
Intracranial Meningiomas, WHO Grade Il : Prognostic Implications of Clinicopathologic Features. J Korean Neurosurg Soc (2012) 0.80
Dural attachment of intracranial meningiomas: evaluation with contrast-enhanced three-dimensional fast imaging with steady-state acquisition (FIESTA) at 3 T. Neuroradiology (2010) 0.80
Magnetic resonance imaging, computed tomography, and 68Ga-DOTATOC positron emission tomography for imaging skull base meningiomas with infracranial extension treated with stereotactic radiotherapy--a case series. Head Face Med (2012) 0.80
Meningiomas of the internal auditory canal: two case reports. Skull Base (2002) 0.79
Surgical treatment of intraspinal angiomatous meningiomas from a single center. Neurol Med Chir (Tokyo) (2015) 0.79
Linac-based stereotactic radiotherapy and radiosurgery in patients with meningioma. Radiat Oncol (2014) 0.79
Development of patient-derived xenograft models from a spontaneously immortal low-grade meningioma cell line, KCI-MENG1. J Transl Med (2015) 0.79
Is Simpson grade I removal necessary in all cases of spinal meningioma? Assessment of postoperative recurrence during long-term follow-up. Neurol Med Chir (Tokyo) (2014) 0.78
Cell kinetics of the malignant evolution of meningothelial meningioma. Acta Neuropathol (1987) 0.78
Intracranial meningiomas. Analysis of 344 surgically treated cases. Neurosurg Rev (1998) 0.77
The Role of the Pterional Approach in the Surgical Treatment of Olfactory Groove Meningiomas: A 20-year Experience. J Neurol Surg B Skull Base (2013) 0.77
The role of imaging in the follow up of meningiomas. J Neurol Neurosurg Psychiatry (1995) 0.77
Expression of endothelin 1 and its angiogenic role in meningiomas. Virchows Arch (2006) 0.77
Reirradiation of recurrent meningioma. J Clin Neurosci (2012) 0.76
Mast cells in meningiomas and brain inflammation. J Neuroinflammation (2015) 0.76
A prospective study of cavernous sinus surgery for meningiomas and resultant common ophthalmic complications (an American Ophthalmological Society thesis). Trans Am Ophthalmol Soc (2007) 0.76
Totally ossified metaplastic spinal meningioma. J Korean Neurosurg Soc (2013) 0.76
[Meningiomas: multiparametric approach for risk stratification and grading]. Pathologe (2008) 0.76
A case of cervical spine meningioma following etanercept use in a patient with RA. Nat Rev Rheumatol (2009) 0.75
Radiotherapy and intracranial meningiomas causing visual disturbance. Br J Ophthalmol (2005) 0.75
Long term outcome analysis of role of radiotherapy in Grade I meningiomas: A single centre experience from North India. Int J Appl Basic Med Res (2015) 0.75
An extracranial invasive meningioma mimicking malignant bone tumor - "carpet meningioma". J Clin Diagn Res (2013) 0.75
Skull base meningioma: delayed extracranial presentation. Skull Base (2001) 0.75
Asterion meningiomas. Skull Base Surg (1998) 0.75
Posterolateral approach for spinal intradural meningioma with ventral attachment. J Craniovertebr Junction Spine (2015) 0.75
Predictive factors for surgical outcome in anterior clinoidal meningiomas: Analysis of 59 consecutive surgically treated cases. Medicine (Baltimore) (2017) 0.75
Lessons from surgical outcome for intracranial meningioma involving major venous sinus. Medicine (Baltimore) (2016) 0.75
Internal carotid artery sacrifice for radical resection of skull base tumors. Skull Base Surg (1996) 0.75
Invasive character of an intradural spinal meningioma in early childhood. Childs Nerv Syst (1993) 0.75
Recurrent spinal meningioma: a case report. Korean J Spine (2012) 0.75
Surgical results after unilateral laminectomy for the removal of spinal cord tumors. Korean J Spine (2012) 0.75
Expression of merlin, NDRG2, ERBB2, and c-MYC in meningiomas: relationship with tumor grade and recurrence. Braz J Med Biol Res (2016) 0.75
Establishment of a molecular cytogenetic analysis for native tumor tissue of meningiomas-suitable for clinical application. Mol Cytogenet (2014) 0.75
Outcomes and complications of gamma knife radiosurgery for skull base meningiomas. J Neurol Surg B Skull Base (2014) 0.75
Aminolevulinic acid-mediated photodynamic therapy of human meningioma: an in vitro study on primary cell lines. Int J Mol Sci (2015) 0.75
Long term clinical outcomes of malignant meningiomas. Brain Tumor Res Treat (2013) 0.75
Commentary on Meningioma paper. Br J Neurosurg (2008) 0.75
Review of Current Evidence Regarding Surgery in Elderly Patients with Meningioma. Neurol Med Chir (Tokyo) (2017) 0.75
68Ga-DOTA-D Phe1-Tyr3-Octreotide (DOTATOC)-PET/CT in a Suspected Case of Recurrent Meningioma. Indian J Nucl Med (2017) 0.75
Operative strategies in ventrally and ventrolaterally located spinal meningiomas and review of the literature. Neurosurg Rev (2013) 0.75
Non-schwannomatosis lesions of the internal acoustic meatus-a diagnostic challenge and management: a series report of nine cases. Neurosurg Rev (2015) 0.75
Long-term evaluation of the effect of hypofractionated high-energy proton treatment of benign meningiomas by means of (11)C-L-methionine positron emission tomography. Eur J Nucl Med Mol Imaging (2016) 0.75
Slip interface imaging based on MR-elastography preoperatively predicts meningioma-brain adhesion. J Magn Reson Imaging (2017) 0.75
Primary extra-cranial meningioma following total hip replacement. Skeletal Radiol (2008) 0.75
Improved survival in patients with locally advanced prostate cancer treated with radiotherapy and goserelin. N Engl J Med (1997) 8.72
Conditionally replicating herpes simplex virus mutant, G207 for the treatment of malignant glioma: results of a phase I trial. Gene Ther (2000) 4.33
Loss of genes on chromosome 22 in tumorigenesis of human acoustic neuroma. Nature (1986) 3.40
Attenuated multi-mutated herpes simplex virus-1 for the treatment of malignant gliomas. Nat Med (1995) 3.37
Spinal epidural abscess. N Engl J Med (1975) 2.64
Replication-selective virotherapy for cancer: Biological principles, risk management and future directions. Nat Med (2001) 2.64
Genetic linkage of bilateral acoustic neurofibromatosis to a DNA marker on chromosome 22. Nature (1987) 2.32
Thresholds of focal cerebral ischemia in awake monkeys. J Neurosurg (1981) 2.23
Common pathogenetic mechanism for three tumor types in bilateral acoustic neurofibromatosis. Science (1987) 2.06
Oncolytic herpes simplex virus vector with enhanced MHC class I presentation and tumor cell killing. Proc Natl Acad Sci U S A (2001) 1.99
Herpes simplex virus as an in situ cancer vaccine for the induction of specific anti-tumor immunity. Hum Gene Ther (1999) 1.84
Treatment of malignant tumors of the spermatic cord: a study of 10 cases and a review of the literature. J Urol (1981) 1.82
Cerebellar hemorrhage: diagnosis and treatment. A review of 56 cases. Arch Neurol (1974) 1.65
Intramedullary cavernous angiomas of the spinal cord: clinical presentation, pathological features, and surgical management. Neurosurgery (1992) 1.65
Molecular genetic approach to human meningioma: loss of genes on chromosome 22. Proc Natl Acad Sci U S A (1987) 1.63
Pediatric medulloblastoma: radiation treatment technique and patterns of failure. Int J Radiat Oncol Biol Phys (1997) 1.62
Angiographically occult arteriovenous malformations. J Neurosurg (1988) 1.61
Further experience with the syndrome of "normal" pressure hydrocephalus. J Neurosurg (1969) 1.59
Combined chemotherapy and radiotherapy, followed or not by surgery, in squamous cell carcinoma of the esophagus. Ann Oncol (1995) 1.48
[Lambert-Eaton myasthenic syndrome. Physiopathological aspects and therapeutic modalities]. Rev Neurol (Paris) (1991) 1.47
Cerebral vasospasm with ruptured saccular aneurysm--the clinical manifestations. Neurosurgery (1978) 1.45
Definitive radiation therapy for chordoma and chondrosarcoma of base of skull and cervical spine. J Neurosurg (1982) 1.44
Cingulotomy for refractory obsessive-compulsive disorder. A long-term follow-up of 33 patients. Arch Gen Psychiatry (1991) 1.44
Act locally, think globally. Nat Med (1997) 1.43
Systemic antitumor immunity in experimental brain tumor therapy using a multimutated, replication-competent herpes simplex virus. Hum Gene Ther (1999) 1.43
Conjunctival lymphoma: results and treatment with a single anterior electron field. A lens sparing approach. Int J Radiat Oncol Biol Phys (1990) 1.42
Treatment of malignant gliomas using ganciclovir-hypersensitive, ribonucleotide reductase-deficient herpes simplex viral mutant. Cancer Res (1994) 1.41
Reduction and elimination of encephalitis in an experimental glioma therapy model with attenuated herpes simplex mutants that retain susceptibility to acyclovir. Neurosurgery (1993) 1.39
Use of intraoperative auditory evoked potentials to preserve hearing in unilateral acoustic neuroma removal. J Neurosurg (1984) 1.36
Bilateral acoustic neuromas: clinical aspects, pathogenesis, and treatment. Neurosurgery (1982) 1.34
Spontaneous dissection of cervico-cerebral arteries. Can J Neurol Sci (1978) 1.32
Association of epidermal growth factor receptor gene amplification with loss of chromosome 10 in human glioblastoma multiforme. J Neurosurg (1992) 1.28
Mediastinal large cell lymphoma. An uncommon subset of adult lymphoma curable with combined modality therapy. Cancer (1988) 1.26
Attenuated, replication-competent herpes simplex virus type 1 mutant G207: safety evaluation of intracerebral injection in nonhuman primates. J Virol (1999) 1.26
Benign spinal nerve sheath tumors: their occurrence sporadically and in neurofibromatosis types 1 and 2. J Neurosurg (1991) 1.25
A treatment planning inter-comparison of proton and intensity modulated photon radiotherapy. Radiother Oncol (1999) 1.24
Selective killing of glioma cells in culture and in vivo by retrovirus transfer of the herpes simplex virus thymidine kinase gene. New Biol (1991) 1.22
Treatment of human malignant meningiomas by G207, a replication-competent multimutated herpes simplex virus 1. Cancer Res (1995) 1.22
Diagnosis, treatment, and outcome of pituitary tumors and other abnormal intrasellar masses. Retrospective analysis of 353 patients. Medicine (Baltimore) (1999) 1.20
Small cell anaplastic carcinoma of the prostate: seven new cases, review of the literature, and discussion of a therapeutic strategy. Am J Clin Oncol (1997) 1.18
Direct spinal arteriovenous fistula: a new type of spinal AVM. Case report. J Neurosurg (1986) 1.16
Adjuvant postoperative radiotherapy in carcinoma of the rectum and rectosigmoid. Cancer (1985) 1.15
Surgical treatment of acoustic neuroma (vestibular schwannoma) in the United States: report from the Acoustic Neuroma Registry. Laryngoscope (1996) 1.15
Prognostic factors in urothelial renal pelvis and ureter tumours: a multicentre Rare Cancer Network study. Eur J Cancer (1999) 1.14
The angiogenic factor midkine is aberrantly expressed in NF1-deficient Schwann cells and is a mitogen for neurofibroma-derived cells. Oncogene (2001) 1.13
In situ cancer vaccination: an IL-12 defective vector/replication-competent herpes simplex virus combination induces local and systemic antitumor activity. J Immunol (1998) 1.13
Large and giant paraclinoid aneurysms: surgical techniques, complications, and results. Neurosurgery (1983) 1.13
Replication-competent herpes simplex virus vector G207 and cisplatin combination therapy for head and neck squamous cell carcinoma. Neoplasia (1999) 1.13
Local and systemic therapy of human prostate adenocarcinoma with the conditionally replicating herpes simplex virus vector G207. Hum Gene Ther (1999) 1.13
Clinical review--breast adenoid cystic carcinoma. Breast (2011) 1.13
Transfer and expression of the lacZ gene in rat brain neurons mediated by herpes simplex virus mutants. New Biol (1990) 1.13
Intracarotid delivery of oncolytic HSV vector G47Delta to metastatic breast cancer in the brain. Gene Ther (2005) 1.13
Preservation of hearing and facial nerve function in resection of acoustic neuroma. Laryngoscope (1992) 1.12
The relation of cerebral vasospasm to the extent and location of subarachnoid blood visualized by CT scan: a prospective study. Neurology (1983) 1.12
Induction treatment before surgery for non-small cell lung cancer. Lung Cancer (2003) 1.12
Simultaneous determination of deoxyribonucleoside in the presence of ribonucleoside triphosphates in human carcinoma cells by high-performance liquid chromatography. Anal Biochem (1999) 1.12
Enhanced therapeutic efficacy of IL-12, but not GM-CSF, expressing oncolytic herpes simplex virus for transgenic mouse derived prostate cancers. Cancer Gene Ther (2006) 1.11
Gene delivery to glioma cells in rat brain by grafting of a retrovirus packaging cell line. J Neurosci Res (1990) 1.10
Intravenous nitroglycerin in experimental cerebral vasospasm. A preliminary report. Stroke (1979) 1.09
Temporal clustering of hemorrhages from untreated cavernous malformations of the central nervous system. Neurosurgery (2001) 1.09
Viral shedding and biodistribution of G207, a multimutated, conditionally replicating herpes simplex virus type 1, after intracerebral inoculation in aotus. Mol Ther (2000) 1.08
Gene therapy of malignant brain tumors: a rat glioma line bearing the herpes simplex virus type 1-thymidine kinase gene and wild type retrovirus kills other tumor cells. J Neurosci Res (1992) 1.08
Treatment of human breast cancer in a brain metastatic model by G207, a replication-competent multimutated herpes simplex virus 1. Hum Gene Ther (1998) 1.07
Central nervous system neurocytoma and neuroblastoma in adults--report of eight cases. J Neurooncol (1990) 1.07
Neurofibromatosis type 2 appears to be a genetically homogeneous disease. Am J Hum Genet (1992) 1.07
Intramedullary spinal cord astrocytoma versus glioblastoma: the prognostic importance of histologic grade. Cancer (1982) 1.06
CSF shunts for dementia, incontinence, and gait disturbance. Clin Neurosurg (1985) 1.05
Attenuated, replication-competent herpes simplex virus type 1 mutant G207: safety evaluation in mice. J Virol (2000) 1.05
Flanking markers bracket the neurofibromatosis type 2 (NF2) gene on chromosome 22. Am J Hum Genet (1990) 1.04
Endolymphatic sac tumors: histopathologic confirmation, clinical characterization, and implication in von Hippel-Lindau disease. Laryngoscope (1995) 1.04
Estrogen and progestin binding by cytosolic and nuclear fractions of human meningiomas. J Neurosurg (1985) 1.04
Transcriptional targeting of herpes simplex virus for cell-specific replication. J Virol (1997) 1.03
AGM-1470 inhibits the growth of human glioblastoma cells in vitro and in vivo. Neurosurgery (1994) 1.02
Double-blind, randomized clinical study comparing hyaluronic acid cream to placebo in patients treated with radiotherapy. Radiother Oncol (1997) 1.02
Preservation of hearing in surgical removal of acoustic neuromas of the internal auditory canal and cerebellar pontine angle. Laryngoscope (1987) 1.02
The management of pineal area tumors: a recent reappraisal. Cancer (1980) 1.02
Radiotherapy of choroidal metastases. Radiother Oncol (1998) 1.01
Oncolytic herpes simplex virus vectors and taxanes synergize to promote killing of prostate cancer cells. Cancer Gene Ther (2009) 1.01
The role of radiotherapy in the treatment of subtotally resected benign meningiomas. J Neurooncol (1992) 1.01
Preoperative irradiation for unresectable rectal and rectosigmoid carcinomas. Cancer (1983) 1.00
Ureteroarterial fistulas after radical pelvic surgery: pathogenesis, diagnosis, and therapeutic modalities. Int J Gynecol Cancer (2007) 0.99
Loss of distinct regions on the short arm of chromosome 17 associated with tumorigenesis of human astrocytomas. Proc Natl Acad Sci U S A (1989) 0.99
Mucosa-associated lymphoid tissue lymphoma of the stomach: long term outcome after local treatment. Cancer (1999) 0.99
Limb salvage by neoadjuvant isolated perfusion with TNFalpha and melphalan for non-resectable soft tissue sarcoma of the extremities. Eur J Surg Oncol (2000) 0.99
Primary lymphoma of bone: the relationship of morphologic diversity to clinical behavior. Cancer (1982) 0.99
Spontaneous dissecting aneurysm of the internal carotid artery. Stroke (1972) 0.99
Primary non-Hodgkin's lymphoma of the mediastinum. Cancer (1982) 0.98
Accelerated radiotherapy, carbogen, and nicotinamide in glioblastoma multiforme: report of European Organization for Research and Treatment of Cancer trial 22933. J Clin Oncol (1999) 0.98
Preclinical safety evaluation of G207, a replication-competent herpes simplex virus type 1, inoculated intraprostatically in mice and nonhuman primates. Hum Gene Ther (2001) 0.98
Modulation of meningioma cell growth by sex steroid hormones in vitro. J Neurosurg (1985) 0.97
Laser-induced fluorescence: experimental intraoperative delineation of tumor resection margins. J Neurosurg (1992) 0.97
Skull-base surgery: a perspective. J Neurosurg (1992) 0.97
Medulloblastoma. The identification of prognostic subgroups and implications for multimodality management. Cancer (1983) 0.96
Management of intramedullary spinal cord tumors. Radiology (1980) 0.96
Spontaneous brain hemorrhage. Stroke (1984) 0.96